The Effects of Different Types of Exercise on Pulmonary Inflammation and Fibrosis in Mice with Type 2 Diabetes Mellitus

QR Code

The Effects of Different Types of Exercise on Pulmonary Inflammation and Fibrosis in Mice with Type 2 Diabetes Mellitus

<b>Background:</b> Diabetic lung disease, characterized by inflammation and fibrosis, is an emerging chronic complication of type 2 diabetes mellitus (T2DM). However, systematic studies on the effects of exercise interventions remain limited. This study aimed to investigate the impact of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haoyang Gao, Xiaotong Ma, Ze Wang, Danlin Zhu, Yifan Guo, Linlin Zhao, Weihua Xiao
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Cells
Subjects:	type 2 diabetes mellitus exercise diabetic lung disease pulmonary fibrosis pulmonary inflammation
Online Access:	https://www.mdpi.com/2073-4409/14/13/1026
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
by: V. A. Ionin, et al.
Published: (2022-11-01)

Chronic obstructive pulmonary disease and type 2 diabetes mellitus – diseases with cytokine imbalance
by: L. N. Sorokina, et al.
Published: (2024-10-01)

The Management of Pulmonary Fibrosis in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2021-07-01)

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Inflammatory Markers as Predictors of Diabetes Mellitus in Patients with Pulmonary Tuberculosis: A Retrospective Analysis of Hematological Parameters and Clinical Features
by: He X, et al.
Published: (2025-07-01)

Breaking new ground in pulmonary fibrosis: Targeting Pathways and Therapeutic Innovations
by: Swadip Mishra
Published: (2025-04-01)

Prospects for the use of flavonoid substances in pulmonary fibrosis (review of experimental studies)
by: E. A. Gubareva, et al.
Published: (2024-12-01)

Exercise improves pulmonary fibrosis and neurological symptoms via S100A12 inhibition
by: Yan Sun, et al.
Published: (2025-06-01)

Levels of markers of coagulation and fibrinolysis systems in patients with pulmonary tuberculosis with concomitant diabetes mellitus after COVID-19
by: R. Yu. Abdullaev, et al.
Published: (2024-07-01)

Integrins and pulmonary fibrosis: Pathogenic roles and therapeutic opportunities
by: Zhangyang Bi, et al.
Published: (2025-06-01)

Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment
by: Cleopas Martin Rumende
Published: (2021-07-01)

The Effects of Two Different Intensities of Concurrent Training on Pulmonary Function in Female Patients With Type II Diabetes
by: Amirhossein Haghighi, et al.
Published: (2025-07-01)

The role of myocardial fibrosis in the diabetic cardiomyopathy
by: Jinghui Sun, et al.
Published: (2025-06-01)

MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Ambulatory Oxygen for Pulmonary Fibrosis (OxyPuF): a randomised controlled trial and acceptability study
by: Rachel L Adams, et al.
Published: (2025-07-01)

Risk of venous thromboembolic complications in patients with diabetes mellitus and COVID-19
by: D. V. Abramov, et al.
Published: (2023-11-01)

IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
by: A. L. Yudin, et al.
Published: (2018-12-01)

Mice experimental model of diabetes mellitus type ii based on high fat diet
by: L. V. Kapilevich, et al.
Published: (2019-10-01)

Lesions of the nervous system in children with type 1 diabetes mellitus (literature review)
by: E. V. Mukhina, et al.
Published: (2019-05-01)

Fibrosis biomarkers and echocardiographic parameters in patients with type 2 diabetes depending on the degree of albuminuria
by: D. A. Lebedev, et al.
Published: (2021-10-01)

Pulmonary cytotoxicity induced by bleomycin and methotrexate
by: Zh, V, Sheykh, et al.
Published: (2016-03-01)

The effects of exercise intervention on the function of endothelial progenitor cells in atherosclerotic mice with type 2 diabetes mellitus
by: Zheng HUANG, et al.
Published: (2025-06-01)

Clinical features analysis of fulminant type 1 diabetes mellitus
by: Min GAO, et al.
Published: (2025-06-01)

Prospects for Treatment of Idiopathic Pulmonary Fibrosis
by: R. N. Mustafin
Published: (2022-08-01)

Biomarkers of pulmonary fibrosis in COVID-19 and postcovid syndrome
by: M. K. Kurbanaliev, et al.
Published: (2022-10-01)

New Predictive Factors in the Development of Type 2 Diabetes Mellitus
by: Maurio González Hernández
Published: (2023-07-01)

“POSSIBLE” OR “PROBABLE”. THE NEW APPROACH IN IDIOPATHIC PULMONARY FIBROSIS DIAGNOSIS
by: D. V. Petrov, et al.
Published: (2018-08-01)

Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis
by: Eva Cabrera-César, et al.
Published: (2025-05-01)

Role of lipopolysaccharide in genesis of microvascular complications in type 1 diabetes mellitus
by: V. A. Beloglazov, et al.
Published: (2024-11-01)

The Relationship Between Chest Wall Muscle Thickness, Pulmonary Function, and Prognostic Markers in Idiopathic Pulmonary Fibrosis
by: Pelin Pınar Deniz, et al.
Published: (2025-06-01)

Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)

Role of Immune Cells in Mediating the Effect of Hypothyroidism on Idiopathic Pulmonary Fibrosis
by: Zhengling Liu, et al.
Published: (2025-07-01)

Potential Causal Relationship Between Chronic Obstructive Pulmonary Disease and Diabetes: A Bidirectional Two-Sample Mendelian Randomization Study
by: Wang X, et al.
Published: (2025-07-01)

Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis
by: Yuejiao Lan, et al.
Published: (2025-07-01)

Ferroptosis in pulmonary fibrosis: pathogenesis and traditional Chinese medicine-driven therapeutic approaches
by: Xudong Fan, et al.
Published: (2025-07-01)

Obtaining a mouse model of streptozotocininduced type 1 diabetes mellitus
by: G. N. Skaletskaya, et al.
Published: (2024-07-01)

Melittin alleviates bleomycin-induced pulmonary fibrosis in vivo through regulating TGF-β1/Smad2/3 and AMPK/SIRT1/PGC-1α signaling pathways
by: Jiawang Yu, et al.
Published: (2025-04-01)

Determining ACE-2 Level and Some Relevant Biochemical Parameters and studying the effect of Gender in Iraqi Diabetic Patients with Glomeruli and Renal Tubules Fibrosis as Early Prediction Marker
by: Reham Khuldon Ibrahim, et al.
Published: (2023-12-01)

Comparison of clinico-radiological profile of pulmonary tuberculosis in diabetic and non-diabetic patients in a tertiary care hospital – An observational analytical study
by: Asif Iqbal Biswas, et al.
Published: (2025-07-01)

Type 2 Diabetes Mellitus Risk in Physical Exercise Program Users
by: José Ander Asenjo Alarcón
Published: (2020-12-01)